MRNS — Marinus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $30.34m
- $43.35m
- $30.99m
Brief: Marinus Pharmaceuticals - Cash Runway Projected Into Q4 2024
Marinus Pharmaceuticals Inc expected to post a loss of 66 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Bausch Health Companies, Chewy, First Citizens Bancshares
Brief: Marinus Pharmaceuticals says Cash Runway Now Expected Into Q4 Of 2024
Brief: Marinus Pharmaceuticals Says On August 17, The PTAB Granted Co's Petition Seeking Post-Grant Review Of Ovid Therapeutics'
U.S. STOCKS ON THE MOVE-Amylyx Pharma, Bakkt, Aptiv
Refinitiv Newscasts - Trading at Noon: Wall St slides, growth stocks fall after PPI data
U.S. STOCKS ON THE MOVE-Occidental, Illumina, Walmart
Marinus Pharma falls on delay in data readout for seizure treatment, PT cuts
U.S. RESEARCH ROUNDUP-Caci International, Cyberark Software, Ralph Lauren
Marinus Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Marinus Pharmaceuticals Announces European Commission Approval Of ZTALMY
Brief: Adage Capital Partners Reports 5.45% Passive Stake In Marinus Pharmaceuticals As Of June 26
Brief: Marinus Pharmaceuticals Appoints Sarah Noonberg To Board
Marinus Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Marinus Pharmaceuticals Reports Q1 2023 Financial Results, Provides Business Update
Marinus Pharmaceuticals Inc expected to post a loss of 72 cents a share - Earnings Preview
Brief: Marinus Pharma Increased Size Of Board From Seven To Eight Members
Brief: Marinus Pharma Appoints Marvin Johnson To Board Of Directors